Soldi et al. showed that SWI/SNF-deficient ovarian cancer appears to be dependent on LSD1 activity, because SCCOHT and ovarian clear cell carcinoma cell lines are sensitive to SP-2577 (Seclidemstat), a reversible LSD1 inhibitor [24]. This evidence concerns the gene KDM1A and ovarian cancer.